[CONTROL OF HYPERGLYCEMIA IN THE CLINICAL PRACTICE]

Area of Science:

• Clinical Chemistry
• Endocrinology
• Nephrology

Background:

• Hyperglycemia diagnosis relies on fasting plasma glucose, oral glucose tolerance tests, and glycated hemoglobin (HbA1c).
• Critical conditions often involve metabolic disturbances impacting patient outcomes.

Purpose of the Study:

• To determine the significance of glycated hemoglobin (HbA1c) in patients at risk of critical conditions.
• Investigate the role of HbA1c in patients with cerebrovascular diseases, hyperasotemia, and renal insufficiency.

Main Methods:

• Diagnosis of hyperglycemia using fasting plasma glucose and oral glucose tolerance tests.
• Measurement of glycated hemoglobin (HbA1c) levels.
• Analysis of patient groups including those with cerebrovascular diseases, hyperasotemia, and renal insufficiency.

Main Results:

• Hyperglycemia and elevated HbA1c significantly influence cerebral artery tone.
• Hyperasotemia represents a considerable portion of the general population.
• Patients with latent renal insufficiency exhibited increased levels of glycated hemoglobin.

Conclusions:

• Glycated hemoglobin (HbA1c) determination is valuable for assessing patients with critical conditions.
• HbA1c levels are important indicators in patients with cerebrovascular diseases and renal insufficiency.
• Monitoring HbA1c can aid in managing patients at risk of severe health events.